Andrew S Goldstein

11PUBLICATIONS
64CO-AUTHORS
Molecular targetsCancer cell biologyPredictive and prognostic markersMedical physics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 02, 2026
Polyamine Metabolism as a Metabolic Vulnerability in Prostate Cancer Treated with Supraphysiological Androgens.

Mohammadreza Alizadeh-Ghodsi, Andrew S Goldstein

|Jan 27, 2026
OGDHL Promotes Prostate Cancer Progression and Regulates Neuroendocrine Marker Expression and Nucleotide Abundance.

Matthew J Bernard, Andrea Gallardo, Angel Ruiz

|Sep 08, 2025
Defining aging-associated factors that increase susceptibility to prostate cancer.

Shile Zhang, Ernie Lee, Sachi Bopardikar

|Jun 12, 2025
OGDHL regulates tumor growth, neuroendocrine marker expression, and nucleotide abundance in prostate cancer.

Matthew J Bernard, Angel Ruiz, Johnny A Diaz

|Feb 08, 2024
A Metabolic-Epigenetic Mechanism Directs Cell Fate and Therapeutic Sensitivity in Breast Cancer.

Matthew J Bernard, Andrew S Goldstein

|Dec 04, 2023
Prostate lineage-specific metabolism governs luminal differentiation and response to antiandrogen treatment.

Jenna M Giafaglione, Preston D Crowell, Amelie M L Delcourt

Pageof 2